Literature DB >> 17487380

Epigenetic DNA-methylation regulation of genes coding for lipid raft-associated components: a role for raft proteins in cell transformation and cancer progression (review).

Samir K Patra1, Saverio Bettuzzi.   

Abstract

Metastatic progression is the cause of most cancer deaths. Host tumour cell separation (fission) is accompanied by simultaneous acquisition of migrating capability of cancer cells, remodeling of cellular architecture and effective 'homing' in body host environment. Cell remodeling involves cytoskeletal protein-protein and lipid-protein interaction together with altered signaling. Alteration of signaling in tumour cells may affect expression of many genes also by DNA-methylation/demethylation. This would alter the steady-state intracellular level of structural proteins or metabolic enzymes, and notably enzymes involved in the biosynthesis of lipids, affecting the composition of membranes. Lipid rafts are small, heterogeneous, highly dynamic, sterol- and sphingolipid-enriched domains that compartmentalize cellular processes. Small rafts can be stabilized to form larger platforms through protein-protein and protein-lipid interactions. Lipid rafts play an important role in intracellular protein transport, membrane fusion and trans-cytosis, also being platforms for cell surface antigens and adhesion molecules which are crucial for cell activation, polarization and signaling. Detachment of individual tumour cells from the host tumour lump requires lipid-protein-lipid raft (LPLR) reordering. Lipid rafts are also involved in angiogenesis and local invasion, which occurs within the host tumour vicinity by exchange of enzymes, cytokines and motility factors that modify the surrounding extracellular matrix (ECM). Many cell surface adhesion, ECM, and signaling proteins (such as E-cadherin, catenin, CD44, MMP-9 and caveolin-1) are known to be absent or reduced following gene promoter-CpG-island hypermethylation in mid-stage growing tumours, but re-expressed (by gene promoter-mCpG-DNA demethylation) in carcinomas such as metastasized lung, prostate and sarcomas. The recent research acquisitions on lipid rafts have tremendous implications in understanding the genetic and biochemical bases of metastatic diffusion of cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487380

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  17 in total

1.  Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer.

Authors:  Seung-Chul Pack; Hye-Ran Kim; Sang-Woo Lim; Hwan-Young Kim; Jung-Yun Ko; Ki-Sang Lee; David Hwang; Seong-Il Park; Hoon Kang; Sang-Wook Park; Gun-Young Hong; Se-Min Hwang; Myung-Geun Shin; Soong Lee
Journal:  Int J Colorectal Dis       Date:  2012-09-19       Impact factor: 2.571

2.  Epigenetic regulation of matrix metalloproteinases and their collagen substrates in cancer.

Authors:  Andrei V Chernov; Alex Y Strongin
Journal:  Biomol Concepts       Date:  2011-06

3.  DNA methylation in promoter region as biomarkers in prostate cancer.

Authors:  Mihi Yang; Jong Y Park
Journal:  Methods Mol Biol       Date:  2012

4.  Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy.

Authors:  Mingqing Tang; William Xu; Qizhao Wang; Weidong Xiao; Ruian Xu
Journal:  Curr Genomics       Date:  2009-08       Impact factor: 2.236

5.  Effects of high glucose on caveolin-1 and insulin signaling in 3T3-L1 adipocytes.

Authors:  Sara Palacios-Ortega; Maider Varela-Guruceaga; J Alfredo Martínez; Carlos de Miguel; Fermín I Milagro
Journal:  Adipocyte       Date:  2015-12-08       Impact factor: 4.534

6.  Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells.

Authors:  Si Jin; Fan Yi; Fan Zhang; Justin L Poklis; Pin-Lan Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-04       Impact factor: 8.311

7.  α-bisabolol is an effective proapoptotic agent against BCR-ABL(+) cells in synergism with Imatinib and Nilotinib.

Authors:  Massimiliano Bonifacio; Antonella Rigo; Emanuele Guardalben; Christian Bergamini; Elisabetta Cavalieri; Romana Fato; Giovanni Pizzolo; Hisanori Suzuki; Fabrizio Vinante
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

8.  Molecular marks for epigenetic identification of developmental and cancer stem cells.

Authors:  Samir Kumar Patra; Moonmoon Deb; Aditi Patra
Journal:  Clin Epigenetics       Date:  2010-12-17       Impact factor: 6.551

9.  High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Shi-Hong Zhang; Chan-Juan Wang; Ling Shi; Xing-Hua Li; Jing Zhou; Li-Bing Song; Wen-Ting Liao
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

10.  Elucidation of caveolin 1 both as a tumor suppressor and metastasis promoter in light of epigenetic modulators.

Authors:  Moonmoon Deb; Dipta Sengupta; Swayamsiddha Kar; Sandip Kumar Rath; Sabnam Parbin; Arunima Shilpi; Subhendu Roy; Gautam Das; Samir Kumar Patra
Journal:  Tumour Biol       Date:  2014-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.